Bottom line
PILL vs MIDU: the short answer
PILL (Direxion Daily Pharmaceutical & Medical Bull 3X ETF) and MIDU (Direxion Daily Mid Cap Bull 3X ETF) are both etfs.
But MIDU is far broader, holding 406 positions to 73 for PILL, so beyond the top names it adds exposure PILL doesn't have.
Both charge the same expense ratio (0.98%).
Over five years, MIDU returned +5.5% a year vs −12.6% for PILL.
Updated Nov 19, 2026
PILL vs MIDU side by side
| PILL | MIDU | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | Direxion | Direxion |
| Category | Leveraged & Inverse | Leveraged & Inverse |
| Expense ratio | 0.98% | 0.98% |
| Annual cost per $10k | $98 | $98 |
| 10-yr cost on $10k (prospectus) | $1,456 | $1,212 |
| Max front load | None | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +75.0% | −2.7% |
| 5-yr return (annualized) | −12.6% | +5.5% |
| 10-yr return (annualized) | — | +10.4% |
| Best quarter | +103.7% | +85.8% |
| Worst quarter | −61.4% | −75.8% |
| Net assets (fund) | $20.7M | $68.6M |
| Number of holdings | 73 | 406 |
| Portfolio turnover | 88% | 48% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | PILL | MIDU | Difference |
|---|---|---|---|
| 2025 | +75.0% | −2.7% | +77.7% |
| 2024 | −6.9% | +20.3% | −27.2% |
| 2023 | −12.7% | +27.6% | −40.2% |
| 2022 | −43.1% | −49.2% | +6.0% |
| 2021 | −37.2% | +72.5% | −109.7% |
| 2020 | −0.3% | −18.2% | +17.9% |
| 2019 | +18.2% | +76.8% | −58.6% |
| 2018 | −19.6% | −39.0% | +19.4% |
Source: Fund prospectus bar charts
Holdings overlap
4 of PILL's top 25 holdings also appear in MIDU's top 25.
| Holding | PILL | MIDU |
|---|---|---|
| Goldman Financial | 22.36% | 18.37% |
| N/a | 16.36% | 1.28% |
| Dreyfus | 8.14% | 5.98% |
| N/a | 7.41% | 1.28% |
Source: SEC Form N-PORT
PILL top 10
- Goldman Financial — 22.36%
- N/a — 16.36%
- Dreyfus — 8.14%
- N/a — 7.41%
- Crinetics Pharmaceuticals In — 2.77%
- Mbx Biosciences Inc — 2.42%
- Ataibeckley Inc — 2.16%
- Definium Therapeutics, Inc — 2.13%
- Goldman Sachs Liq Es Fd A — 2.03%
- Amylyx Pharmaceuticals Inc — 1.72%
MIDU top 10
- Goldman Financial — 18.37%
- N/a — 8.23%
- Dreyfus — 5.98%
- N/a — 4.94%
- N/a — 4.37%
- N/a — 1.28%
- Illumina Inc — 0.66%
- Twilio Inc - A — 0.64%
- Technipfmc Plc — 0.61%
- Curtiss-wright Corp — 0.57%
FAQ
What is the difference between PILL and MIDU?
Which is cheaper, PILL or MIDU?
Should I own both PILL and MIDU?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.